Syndax Pharmaceuticals Inc

By person

19 insiders · 130 transactions

15.5×

Michael A. Metzger holds 15.5 times base salary in stock. $11.75M of shares against $754.30K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael A. Metzger last reported holding, valued at $24.24, the price Common Stock was last bought or sold at on the open market here, on 8 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Morrison Briggs

Director

$311.64K (4)

$26.01M (25) scheduled

−$25.70M

34,836

0.0390%

$844.43K

+1,207%

Metzger Michael A

Chief Executive Officer

—

$15.40M (34) scheduled

−$15.40M

484,843

0.5430%

$11.75M

—

Ordentlich Peter

Chief Scientific Officer

—

$2.81M (14) scheduled

−$2.81M

0.0000%

$0.00

−100.0%

Podlesak Dennis

Director

$197.08K (1)

$2.77M (6) scheduled

−$2.58M

239,763

0.2685%

$5.81M

—

Legault Pierre

Director

—

$2.55M (7) scheduled

−$2.55M

114,000

0.1277%

$2.76M

—

Meury William

Director

—

$1.70M (3) scheduled

−$1.70M

90,000

0.1008%

$2.18M

—

Botwood Nicholas A.J.

Head of R&D, CMO

$105.83K (1)

$1.18M (2) scheduled

−$1.08M

60,885

0.0682%

$1.48M

+6,780%

Egros Fabrice

Director

—

$1.00M (7) scheduled

−$1.00M

32,000

0.0358%

$775.69K

—

Katkin Keith

Director

$91.12K (1)

$877.19K (8) scheduled

−$786.07K

124,000

0.1389%

$3.01M

—

Goldan Keith A.

Chief Financial Officer

$25.04K (2)

$220.45K (6)

−$195.42K

139,252

0.1559%

$3.38M

—

Gallagher Neil

President, Head of R&D

—

$71.60K (1)

−$71.60K

85,095

0.0953%

$2.06M

—

Huber Martin H. Jr.

Director

$44.95K (1)

—

+$44.95K

103,000

0.1153%

$2.50M

—

Nolte Alexander

Chief Accounting Officer

—

$16.12K (1)

−$16.12K

0.0000%

$0.00

—

Meyers Michael L.

SVP, Chief Medical Officer

$14.12K (4)

—

+$14.12K

23,280

0.0261%

$564.31K

+955.3%

ROYSTON IVOR

Director

—

625,545

0.7005%

$15.16M

−16.7%

Jarrett Jennifer

Director

—

114,000

0.1277%

$2.76M

—

BVF PARTNERS L P/IL entity

10% owner

—

85,038

0.0952%

$2.06M

−95.9%

Rizo Aleksandra

Director

—

49,000

0.0549%

$1.19M

—

Shea Richard P

Chief Financial Officer

—

7,121

0.0080%

$172.61K

+320.4%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Katkin Keith

19 May 2025

Director

Buy

10,000

$9.11

$91.12K

Huber Martin H. Jr.

19 May 2025

Director

Buy

5,000

$8.99

$44.95K

Goldan Keith A.

19 May 2025

Chief Financial Officer

Buy

3,000

—

no price

Botwood Nicholas A.J.

16 May 2025

Head of R&D, CMO

Buy

11,765

$9.00

$105.83K

Goldan Keith A.

14 Jun 2024

Chief Financial Officer

Buy

1,250

$20.03

$25.04K

Meyers Michael L.

26 Apr 2021

SVP, Chief Medical Officer

Buy

500

$15.46

$7.73K

Podlesak Dennis

22 Apr 2021

Director

Buy

13,967

$14.11

$197.08K

Morrison Briggs

4 Feb 2020

Chief Executive Officer

Buy

12,500

$8.00

$100.00K

Morrison Briggs

10 Oct 2019

Chief Executive Officer

Buy

11,000

$5.40

$59.40K

Morrison Briggs

13 May 2019

Chief Executive Officer

Buy

7,200

$7.29

$52.52K

Morrison Briggs

9 May 2019

Chief Executive Officer

Buy

13,200

$7.56

$99.73K

Meyers Michael L.

21 Mar 2019

SVP, Chief Medical Officer

Buy

104

$4.87

$506.48

Meyers Michael L.

21 Mar 2019

SVP, Chief Medical Officer

Buy

1,000

$4.93

$4.93K

Meyers Michael L.

30 Oct 2018

SVP, Chief Medical Officer

Buy

200

$4.79

$958.00

Show all 130 transactions →

Syndax Pharmaceuticals Inc

By person

Individual transactions

What was left out